Serving hundreds of leading biopharmaceutical companies globally:

Generated: September 23, 2018

DrugPatentWatch Database Preview

Forest Labs Llc Company Profile

« Back to Dashboard

What is the competitive landscape for FOREST LABS LLC, and what generic alternatives to FOREST LABS LLC drugs are available?

FOREST LABS LLC has two approved drugs.

There are ten US patents protecting FOREST LABS LLC drugs.

Summary for Forest Labs Llc

US Patents:	10
Tradenames:	2
Ingredients:	2
NDAs:	2

Drugs and US Patents for Forest Labs Llc

+ Get email alerts for changes to this table

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Forest Labs Llc	NAMENDA XR	memantine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022525-003	Jun 21, 2010	AB	RX	Yes	No		➤ Sign Up				➤ Sign Up
Forest Labs Llc	NAMENDA XR	memantine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022525-003	Jun 21, 2010	AB	RX	Yes	No	8,362,085*PED	➤ Sign Up			Y	➤ Sign Up
Forest Labs Llc	NAMENDA XR	memantine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022525-001	Jun 21, 2010	AB	RX	Yes	No	8,168,209*PED	➤ Sign Up			Y	➤ Sign Up
Forest Labs Llc	SAPHRIS	asenapine maleate	TABLET;SUBLINGUAL	022117-003	Mar 12, 2015		RX	Yes	No	7,741,358*PED	➤ Sign Up			Y	➤ Sign Up
Forest Labs Llc	NAMENDA XR	memantine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022525-004	Jun 21, 2010	AB	RX	Yes	Yes	8,173,708*PED	➤ Sign Up			Y	➤ Sign Up
Forest Labs Llc	NAMENDA XR	memantine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022525-003	Jun 21, 2010	AB	RX	Yes	No	8,173,708*PED	➤ Sign Up			Y	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Expired US Patents for Forest Labs Llc

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Forest Labs Llc	NAMENDA XR	memantine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022525-001	Jun 21, 2010	5,061,703*PED	➤ Sign Up
Forest Labs Llc	NAMENDA XR	memantine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022525-004	Jun 21, 2010	5,061,703*PED	➤ Sign Up
Forest Labs Llc	NAMENDA XR	memantine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022525-003	Jun 21, 2010	5,061,703*PED	➤ Sign Up
Forest Labs Llc	NAMENDA XR	memantine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022525-002	Jun 21, 2010	5,061,703*PED	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Paragraph IV (Patent) Challenges for FOREST LABS LLC drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Extended-release Capsules	28 mg	➤ Subscribe	2013-06-12
➤ Subscribe	Extended-release Capsules	7 mg, 14 mg, 21 mg, and 28 mg	➤ Subscribe	2013-06-10
➤ Subscribe	Sublingual Tablets	2.5 mg	➤ Subscribe	2017-07-27
➤ Subscribe	Extended-release Capsules	7 mg, 14 mg, 21 mg, and 28 mg	➤ Subscribe	2013-08-16
➤ Subscribe	Extended-release Capsules	7 mg, 14 mg, 21 mg	➤ Subscribe	2013-06-17
➤ Subscribe	Sublingual Tablets	5 mg and 10 mg	➤ Subscribe	2013-08-13

International Patents for Forest Labs Llc Drugs

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Country	Document Number	Estimated Expiration
Finland	963398	➤ Sign Up
European Patent Office	2243475	➤ Sign Up
Canada	2554959	➤ Sign Up
Mexico	2007006120	➤ Sign Up
Russian Federation	2007140348	➤ Sign Up
Japan	5666087	➤ Sign Up
Country	Document Number	Estimated Expiration

Supplementary Protection Certificates for Forest Labs Llc Drugs

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
02C/035	Belgium	➤ Sign Up	PRODUCT NAME: MEMANTINE; REGISTRATION NO/DATE: EU/1/02/219/001 20020517
C032/2010	Ireland	➤ Sign Up	SPC032/2010: 20101210, EXPIRES: 20200228
2011 00001	Denmark	➤ Sign Up
90035-5.L	Sweden	➤ Sign Up	PRODUCT NAME: ASENAPIN; REG. NO/DATE: EU/1/10/640/001 20100901
39/2010	Austria	➤ Sign Up
C/GB02/046	United Kingdom	➤ Sign Up	PRODUCT NAME: MEMANTINE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS; REGISTERED: UK EU/1/02/219/001 20020515; UK EU/1/02/219/002 20020515; UK EU/1/02/219/003 20020515; UK EU/1/02/219/004 20020515; UK EU/1/02/219/005 20020515; UK EU/1/02/219/006 20020515
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice

Accenture

Argus Health

QuintilesIMS

Fuji

Colorcon

Daiichi Sankyo

UBS

Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.